Product Information
TERIPARATIDE 560 MCG/2.24 ML PEN is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $536.5490 per ML under NDC 00093110616. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
250 ug/mL
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093110616
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
TERIPARATIDE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA208569On Market Since
12/18/2023
Pharmacological Classes
Price Statistics
The NADAC for TERIPARATIDE 560 MCG/2.24 ML PEN has been published 115 times since Apr 17, 2024, and over the history we have for it it has declined 24.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $536.5490 per ML |
|---|---|
| All-time high | $899.9994 (Nov 13, 2024) |
| All-time low | $535.0936 (May 20, 2026) |
| 52-week high | $846.0749 |
| 52-week low | $535.0936 |
| Median price | $739.3950 |
| Average price | $742.3074 |
| Largest weekly change | -20.7% (Oct 22, 2025) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TERIPARATIDE 560 MCG/2.24 ML PEN?
The current National Average Drug Acquisition Cost (NADAC) for TERIPARATIDE 560 MCG/2.24 ML PEN, manufactured by Teva Pharmaceuticals USA Inc., is $536.5490 per ML (NDC 00093110616), effective Jun 24, 2026.
How has the price of TERIPARATIDE 560 MCG/2.24 ML PEN changed over time?
Over the history we have for it, the NADAC for TERIPARATIDE 560 MCG/2.24 ML PEN has declined 24.4%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for TERIPARATIDE 560 MCG/2.24 ML PEN?
Since Apr 17, 2024, the NADAC for TERIPARATIDE 560 MCG/2.24 ML PEN has ranged from a low of $535.0936 (May 20, 2026) to a high of $899.9994 (Nov 13, 2024), with a median of $739.3950 per ML.
Are there cheaper alternatives to TERIPARATIDE 560 MCG/2.24 ML PEN?
4 NADAC-published products share the same active ingredient, strength, and dosage form as TERIPARATIDE 560 MCG/2.24 ML PEN, but none are currently priced below it.
Who manufactures TERIPARATIDE 560 MCG/2.24 ML PEN?
TERIPARATIDE 560 MCG/2.24 ML PEN (NDC 00093110616) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.